Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass

Nicola Troisi; Stefano Michelagnoli; Daniele Adami; Raffaella Berchiolli; Federico Accrocca; Alessio Amico; Andrea Angelini; Luca Arnuzzo; Andrea Ascoli Marchetti; Luca Attisani; Gennaro Bafile; Giuseppe Baldino; Enrico Barbanti; Stefano Bartoli; Raffaello Bellosta; Filippo Benedetto; Raoul Borioni; Franco Briolini; Cristina Busoni; Stefano Camparini; Pierluigi Cappiello; Luciano Carbonari; Francesco Casella; Giovanni Celoria; Andrea Chiama; Emiliano Chisci; Efrem Civilini; Francesco Codispoti; Barbara Conti; Giovanni Coppi; Giovanni De Blasis; Marcello D'Elia; Rossella Di Domenico; Carla Di Girolamo; Leonardo Ercolini; Alessandra Ferrari; Mauro Ferrari; Enzo Forliti; Paolo Frigatti; Dalmazio Frigerio; Pierfrancesco Frosini; Luca Garriboli; Antonio Nicola Giordano; Walter Guerrieri; Antonio Jannello; Mafalda Massara; Maurizio Merlo; Roberto Mezzetti; Tommaso Miccoli; Domenico Milite; Pietro Mingazzini; Marina Muncinelli; Giovanni Nano; Marco Natola; Claudio Novali; Giancarlo Palasciano; Reinhold Perkmann; Federica Persi; David Petruccelli; Mauro Pinelli; Giorgio Poletto; Carla Porta; Carlo Pratesi; Gianguido Pruner; Giovanni Ragazzi; Paolo Righini; Mauro Salvini; Paolo Scovazzi; Carlo Setacci; Alberto Maria Settembrini; Andrea Siani; Roberto Silingardi; Antonino Silvestro; Francesco Talarico; Valerio Tolva; Antonio Trani; Santi Trimarchi; Yamume Tshomba; Gennaro Vigliotti; Daniela Viola; Pietro Volpe; Federico Zani

doi:10.1016/j.jvs.2022.03.884

Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass

Nicola Troisi^*, Stefano Michelagnoli, Daniele Adami, Raffaella Berchiolli, Federico Accrocca, Alessio Amico, Andrea Angelini, Luca Arnuzzo, Andrea Ascoli Marchetti, Luca Attisani, Gennaro Bafile, Giuseppe Baldino, Enrico Barbanti, Stefano Bartoli, Raffaello Bellosta, Filippo Benedetto, Raoul Borioni, Franco Briolini, Cristina Busoni, Stefano CampariniPierluigi Cappiello, Luciano Carbonari, Francesco Casella, Giovanni Celoria, Andrea Chiama, Emiliano Chisci, Efrem Civilini, Francesco Codispoti, Barbara Conti, Giovanni Coppi, Giovanni De Blasis, Marcello D'Elia, Rossella Di Domenico, Carla Di Girolamo, Leonardo Ercolini, Alessandra Ferrari, Mauro Ferrari, Enzo Forliti, Paolo Frigatti, Dalmazio Frigerio, Pierfrancesco Frosini, Luca Garriboli, Antonio Nicola Giordano, Walter Guerrieri, Antonio Jannello, Mafalda Massara, Maurizio Merlo, Roberto Mezzetti, Tommaso Miccoli, Domenico Milite, Pietro Mingazzini, Marina Muncinelli, Giovanni Nano, Marco Natola, Claudio Novali, Giancarlo Palasciano, Reinhold Perkmann, Federica Persi, David Petruccelli, Mauro Pinelli, Giorgio Poletto, Carla Porta, Carlo Pratesi, Gianguido Pruner, Giovanni Ragazzi, Paolo Righini, Mauro Salvini, Paolo Scovazzi, Carlo Setacci, Alberto Maria Settembrini, Andrea Siani, Roberto Silingardi, Antonino Silvestro, Francesco Talarico, Valerio Tolva, Antonio Trani, Santi Trimarchi, Yamume Tshomba, Gennaro Vigliotti, Daniela Viola, Pietro Volpe, Federico Zani

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Background: The aim of this study was to compare the 2-year outcomes of de novo versus postendovascular lesion treatment of femoropopliteal occlusions included in a national, multicenter, observational, prospective registry based on the treatment of critical Limb-threatening IschaeMia with infragenicular Bypass adopting in situ SAphenous VEin technique (LIMBSAVE) registry.Methods: From January 2018 to December 2019, 541 patients from43 centers have been enrolled in the LIMBSAVE registry. Of these patients, 460 were included in the present study: 341 (74.1%) with de novo lesions (DN group) and 119 (25.9%) with postendovascular treatment lesions (PE group). Initial outcome measures were assessed at 30 days after treatment. Furthermore, at the 2-year follow-up, the estimated outcomes of primary patency, primary-assisted patency, secondary patency, and limb salvage were analyzed with Kaplan-Meier curves and compared between groups with the log-rank test.Results: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation. However, compared with DN group, more patients in PE group had a great saphenous vein diameter of less than 3 mm (11.1% vs 21%; P = .007). Intraoperatively, both groups showed similar distal anastomosis sites: below-the-knee popliteal artery (63% DN group, 66.4% PE group) and tibial vessel (37% DN group, 33.6% PE group) (P = .3). The overall mean duration of follow-up was 11.6 months (range, 1-24 months). At the 2-year follow-up, there were no differences between the two groups in terms of primary patency (66.3% DN group vs 74.1% PE group; P = .9), primary-assisted patency (78.2% DN group vs 79.5% PE group; P = .2), secondary patency (85.1% DN group vs 91.4% PE group; P = .2), and limb salvage (95.2% DN group vs 95.1% PE group; P = .9).Conclusions: The LIMBSAVE registry did not show a worsening of overall patency and limb salvages rates at the 2-year follow-up in patients undergoing in situ saphenous bypass after a failed endovascular approach for long femoropopliteal occlusive disease. This finding is in contrast with what has been published in literature.

Lingua originale	Inglese
pagine (da-a)	797-805
Numero di pagine	9
Rivista	Journal of Vascular Surgery
Volume	76
Numero di pubblicazione	3
DOI	https://doi.org/10.1016/j.jvs.2022.03.884
Stato di pubblicazione	Pubblicato - 2022

All Science Journal Classification (ASJC) codes

Chirurgia
Cardiologia e Medicina Cardiovascolare

Keywords

Critical limb-threatening ischemia
In situ saphenous vein
Limb salvage
Peripheral bypass

Accesso al documento

10.1016/j.jvs.2022.03.884

Altri file e collegamenti

Cita questo

Troisi, N., Michelagnoli, S., Adami, D., Berchiolli, R., Accrocca, F., Amico, A., Angelini, A., Arnuzzo, L., Marchetti, A. A., Attisani, L., Bafile, G., Baldino, G., Barbanti, E., Bartoli, S., Bellosta, R., Benedetto, F., Borioni, R., Briolini, F., Busoni, C., ... Zani, F. (2022). Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass. Journal of Vascular Surgery, 76(3), 797-805. https://doi.org/10.1016/j.jvs.2022.03.884

@article{1378f385a7624baea8c3ea02e0f1bd8e,

title = "Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass",

abstract = "Background: The aim of this study was to compare the 2-year outcomes of de novo versus postendovascular lesion treatment of femoropopliteal occlusions included in a national, multicenter, observational, prospective registry based on the treatment of critical Limb-threatening IschaeMia with infragenicular Bypass adopting in situ SAphenous VEin technique (LIMBSAVE) registry.Methods: From January 2018 to December 2019, 541 patients from43 centers have been enrolled in the LIMBSAVE registry. Of these patients, 460 were included in the present study: 341 (74.1\%) with de novo lesions (DN group) and 119 (25.9\%) with postendovascular treatment lesions (PE group). Initial outcome measures were assessed at 30 days after treatment. Furthermore, at the 2-year follow-up, the estimated outcomes of primary patency, primary-assisted patency, secondary patency, and limb salvage were analyzed with Kaplan-Meier curves and compared between groups with the log-rank test.Results: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation. However, compared with DN group, more patients in PE group had a great saphenous vein diameter of less than 3 mm (11.1\% vs 21\%; P = .007). Intraoperatively, both groups showed similar distal anastomosis sites: below-the-knee popliteal artery (63\% DN group, 66.4\% PE group) and tibial vessel (37\% DN group, 33.6\% PE group) (P = .3). The overall mean duration of follow-up was 11.6 months (range, 1-24 months). At the 2-year follow-up, there were no differences between the two groups in terms of primary patency (66.3\% DN group vs 74.1\% PE group; P = .9), primary-assisted patency (78.2\% DN group vs 79.5\% PE group; P = .2), secondary patency (85.1\% DN group vs 91.4\% PE group; P = .2), and limb salvage (95.2\% DN group vs 95.1\% PE group; P = .9).Conclusions: The LIMBSAVE registry did not show a worsening of overall patency and limb salvages rates at the 2-year follow-up in patients undergoing in situ saphenous bypass after a failed endovascular approach for long femoropopliteal occlusive disease. This finding is in contrast with what has been published in literature.",

keywords = "Critical limb-threatening ischemia, In situ saphenous vein, Limb salvage, Peripheral bypass, Critical limb-threatening ischemia, In situ saphenous vein, Limb salvage, Peripheral bypass",

author = "Nicola Troisi and Stefano Michelagnoli and Daniele Adami and Raffaella Berchiolli and Federico Accrocca and Alessio Amico and Andrea Angelini and Luca Arnuzzo and Marchetti, \{Andrea Ascoli\} and Luca Attisani and Gennaro Bafile and Giuseppe Baldino and Enrico Barbanti and Stefano Bartoli and Raffaello Bellosta and Filippo Benedetto and Raoul Borioni and Franco Briolini and Cristina Busoni and Stefano Camparini and Pierluigi Cappiello and Luciano Carbonari and Francesco Casella and Giovanni Celoria and Andrea Chiama and Emiliano Chisci and Efrem Civilini and Francesco Codispoti and Barbara Conti and Giovanni Coppi and \{De Blasis\}, Giovanni and Marcello D'Elia and \{Di Domenico\}, Rossella and \{Di Girolamo\}, Carla and Leonardo Ercolini and Alessandra Ferrari and Mauro Ferrari and Enzo Forliti and Paolo Frigatti and Dalmazio Frigerio and Pierfrancesco Frosini and Luca Garriboli and Giordano, \{Antonio Nicola\} and Walter Guerrieri and Antonio Jannello and Mafalda Massara and Maurizio Merlo and Roberto Mezzetti and Tommaso Miccoli and Domenico Milite and Pietro Mingazzini and Marina Muncinelli and Giovanni Nano and Marco Natola and Claudio Novali and Giancarlo Palasciano and Reinhold Perkmann and Federica Persi and David Petruccelli and Mauro Pinelli and Giorgio Poletto and Carla Porta and Carlo Pratesi and Gianguido Pruner and Giovanni Ragazzi and Paolo Righini and Mauro Salvini and Paolo Scovazzi and Carlo Setacci and Settembrini, \{Alberto Maria\} and Andrea Siani and Roberto Silingardi and Antonino Silvestro and Francesco Talarico and Valerio Tolva and Antonio Trani and Santi Trimarchi and Yamume Tshomba and Gennaro Vigliotti and Daniela Viola and Pietro Volpe and Federico Zani",

year = "2022",

doi = "10.1016/j.jvs.2022.03.884",

language = "English",

volume = "76",

pages = "797--805",

journal = "Journal of Vascular Surgery",

issn = "0741-5214",

publisher = "Elsevier Inc.",

number = "3",

}

Troisi, N, Michelagnoli, S, Adami, D, Berchiolli, R, Accrocca, F, Amico, A, Angelini, A, Arnuzzo, L, Marchetti, AA, Attisani, L, Bafile, G, Baldino, G, Barbanti, E, Bartoli, S, Bellosta, R, Benedetto, F, Borioni, R, Briolini, F, Busoni, C, Camparini, S, Cappiello, P, Carbonari, L, Casella, F, Celoria, G, Chiama, A, Chisci, E, Civilini, E, Codispoti, F, Conti, B, Coppi, G, De Blasis, G, D'Elia, M, Di Domenico, R, Di Girolamo, C, Ercolini, L, Ferrari, A, Ferrari, M, Forliti, E, Frigatti, P, Frigerio, D, Frosini, P, Garriboli, L, Giordano, AN, Guerrieri, W, Jannello, A, Massara, M, Merlo, M, Mezzetti, R, Miccoli, T, Milite, D, Mingazzini, P, Muncinelli, M, Nano, G, Natola, M, Novali, C, Palasciano, G, Perkmann, R, Persi, F, Petruccelli, D, Pinelli, M, Poletto, G, Porta, C, Pratesi, C, Pruner, G, Ragazzi, G, Righini, P, Salvini, M, Scovazzi, P, Setacci, C, Settembrini, AM, Siani, A, Silingardi, R, Silvestro, A, Talarico, F, Tolva, V, Trani, A, Trimarchi, S, Tshomba, Y, Vigliotti, G, Viola, D, Volpe, P & Zani, F 2022, 'Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass', Journal of Vascular Surgery, vol. 76, n. 3, pagg. 797-805. https://doi.org/10.1016/j.jvs.2022.03.884

TY - JOUR

T1 - Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass

AU - Troisi, Nicola

AU - Michelagnoli, Stefano

AU - Adami, Daniele

AU - Berchiolli, Raffaella

AU - Accrocca, Federico

AU - Amico, Alessio

AU - Angelini, Andrea

AU - Arnuzzo, Luca

AU - Marchetti, Andrea Ascoli

AU - Attisani, Luca

AU - Bafile, Gennaro

AU - Baldino, Giuseppe

AU - Barbanti, Enrico

AU - Bartoli, Stefano

AU - Bellosta, Raffaello

AU - Benedetto, Filippo

AU - Borioni, Raoul

AU - Briolini, Franco

AU - Busoni, Cristina

AU - Camparini, Stefano

AU - Cappiello, Pierluigi

AU - Carbonari, Luciano

AU - Casella, Francesco

AU - Celoria, Giovanni

AU - Chiama, Andrea

AU - Chisci, Emiliano

AU - Civilini, Efrem

AU - Codispoti, Francesco

AU - Conti, Barbara

AU - Coppi, Giovanni

AU - De Blasis, Giovanni

AU - D'Elia, Marcello

AU - Di Domenico, Rossella

AU - Di Girolamo, Carla

AU - Ercolini, Leonardo

AU - Ferrari, Alessandra

AU - Ferrari, Mauro

AU - Forliti, Enzo

AU - Frigatti, Paolo

AU - Frigerio, Dalmazio

AU - Frosini, Pierfrancesco

AU - Garriboli, Luca

AU - Giordano, Antonio Nicola

AU - Guerrieri, Walter

AU - Jannello, Antonio

AU - Massara, Mafalda

AU - Merlo, Maurizio

AU - Mezzetti, Roberto

AU - Miccoli, Tommaso

AU - Milite, Domenico

AU - Mingazzini, Pietro

AU - Muncinelli, Marina

AU - Nano, Giovanni

AU - Natola, Marco

AU - Novali, Claudio

AU - Palasciano, Giancarlo

AU - Perkmann, Reinhold

AU - Persi, Federica

AU - Petruccelli, David

AU - Pinelli, Mauro

AU - Poletto, Giorgio

AU - Porta, Carla

AU - Pratesi, Carlo

AU - Pruner, Gianguido

AU - Ragazzi, Giovanni

AU - Righini, Paolo

AU - Salvini, Mauro

AU - Scovazzi, Paolo

AU - Setacci, Carlo

AU - Settembrini, Alberto Maria

AU - Siani, Andrea

AU - Silingardi, Roberto

AU - Silvestro, Antonino

AU - Talarico, Francesco

AU - Tolva, Valerio

AU - Trani, Antonio

AU - Trimarchi, Santi

AU - Tshomba, Yamume

AU - Vigliotti, Gennaro

AU - Viola, Daniela

AU - Volpe, Pietro

AU - Zani, Federico

PY - 2022

Y1 - 2022

N2 - Background: The aim of this study was to compare the 2-year outcomes of de novo versus postendovascular lesion treatment of femoropopliteal occlusions included in a national, multicenter, observational, prospective registry based on the treatment of critical Limb-threatening IschaeMia with infragenicular Bypass adopting in situ SAphenous VEin technique (LIMBSAVE) registry.Methods: From January 2018 to December 2019, 541 patients from43 centers have been enrolled in the LIMBSAVE registry. Of these patients, 460 were included in the present study: 341 (74.1%) with de novo lesions (DN group) and 119 (25.9%) with postendovascular treatment lesions (PE group). Initial outcome measures were assessed at 30 days after treatment. Furthermore, at the 2-year follow-up, the estimated outcomes of primary patency, primary-assisted patency, secondary patency, and limb salvage were analyzed with Kaplan-Meier curves and compared between groups with the log-rank test.Results: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation. However, compared with DN group, more patients in PE group had a great saphenous vein diameter of less than 3 mm (11.1% vs 21%; P = .007). Intraoperatively, both groups showed similar distal anastomosis sites: below-the-knee popliteal artery (63% DN group, 66.4% PE group) and tibial vessel (37% DN group, 33.6% PE group) (P = .3). The overall mean duration of follow-up was 11.6 months (range, 1-24 months). At the 2-year follow-up, there were no differences between the two groups in terms of primary patency (66.3% DN group vs 74.1% PE group; P = .9), primary-assisted patency (78.2% DN group vs 79.5% PE group; P = .2), secondary patency (85.1% DN group vs 91.4% PE group; P = .2), and limb salvage (95.2% DN group vs 95.1% PE group; P = .9).Conclusions: The LIMBSAVE registry did not show a worsening of overall patency and limb salvages rates at the 2-year follow-up in patients undergoing in situ saphenous bypass after a failed endovascular approach for long femoropopliteal occlusive disease. This finding is in contrast with what has been published in literature.

AB - Background: The aim of this study was to compare the 2-year outcomes of de novo versus postendovascular lesion treatment of femoropopliteal occlusions included in a national, multicenter, observational, prospective registry based on the treatment of critical Limb-threatening IschaeMia with infragenicular Bypass adopting in situ SAphenous VEin technique (LIMBSAVE) registry.Methods: From January 2018 to December 2019, 541 patients from43 centers have been enrolled in the LIMBSAVE registry. Of these patients, 460 were included in the present study: 341 (74.1%) with de novo lesions (DN group) and 119 (25.9%) with postendovascular treatment lesions (PE group). Initial outcome measures were assessed at 30 days after treatment. Furthermore, at the 2-year follow-up, the estimated outcomes of primary patency, primary-assisted patency, secondary patency, and limb salvage were analyzed with Kaplan-Meier curves and compared between groups with the log-rank test.Results: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation. However, compared with DN group, more patients in PE group had a great saphenous vein diameter of less than 3 mm (11.1% vs 21%; P = .007). Intraoperatively, both groups showed similar distal anastomosis sites: below-the-knee popliteal artery (63% DN group, 66.4% PE group) and tibial vessel (37% DN group, 33.6% PE group) (P = .3). The overall mean duration of follow-up was 11.6 months (range, 1-24 months). At the 2-year follow-up, there were no differences between the two groups in terms of primary patency (66.3% DN group vs 74.1% PE group; P = .9), primary-assisted patency (78.2% DN group vs 79.5% PE group; P = .2), secondary patency (85.1% DN group vs 91.4% PE group; P = .2), and limb salvage (95.2% DN group vs 95.1% PE group; P = .9).Conclusions: The LIMBSAVE registry did not show a worsening of overall patency and limb salvages rates at the 2-year follow-up in patients undergoing in situ saphenous bypass after a failed endovascular approach for long femoropopliteal occlusive disease. This finding is in contrast with what has been published in literature.

KW - Critical limb-threatening ischemia

KW - In situ saphenous vein

KW - Limb salvage

KW - Peripheral bypass

KW - Critical limb-threatening ischemia

KW - In situ saphenous vein

KW - Limb salvage

KW - Peripheral bypass

UR - https://publicatt.unicatt.it/handle/10807/249274

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85131808064&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85131808064&origin=inward

U2 - 10.1016/j.jvs.2022.03.884

DO - 10.1016/j.jvs.2022.03.884

M3 - Article

SN - 0741-5214

VL - 76

SP - 797

EP - 805

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

IS - 3

ER -

Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo